Free · 13,587 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Feasibility of Multi-Wavelength LED Irradiation on the Skull and Preliminary Glycemic Outcomes in Individuals with Type 2 Diabetes: A Prospective Pilot Study

Multi-wavelength LED irradiation applied to the predefined S3 region of the skull was feasible, safe, and well tolerated in individuals with T2DM.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a prospective pilot study of multi-wavelength LED light applied to a defined region of the skull in seven adults with type 2 diabetes over four weeks. They found that fasting and mean blood glucose decreased significantly, with a borderline HbA1c reduction, and that no adverse events occurred. The authors caution that the small sample and lack of a control group mean the findings do not show clinical efficacy.

Participants
7
Who or what was studied
Adults with physician-diagnosed type 2 diabetes receiving stable antidiabetic medication
Wavelengths
660, 850, 940 nm
Limits stated in the abstract
The abstract notes a small sample size, no control group, and an exploratory design, so the findings should be interpreted cautiously.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by impaired glucose homeostasis, insulin resistance, and progressive β-cell dysfunction. Increasing evidence suggests that glucose homeostasis is regulated not only by peripheral metabolic organs but also by central nervous system and autonomic pathways. Photobiomodulation (PBM) has been reported to modulate mitochondrial function, oxidative stress, vascular responses, and neural activity; however, its potential influence on glycemic outcomes remains largely unexplored.

Objective

This prospective pilot study aimed to evaluate the feasibility of applying multi-wavelength LED irradiation to a predefined cranial region and to explore preliminary glycemic outcomes in individuals with T2DM.

Methods

Seven participants with physician-diagnosed T2DM receiving stable antidiabetic medication regimens were enrolled. Multi-wavelength LED irradiation (660, 850, and 940 nm) was applied bilaterally to the predefined S3 region of the skull. Irradiation parameters included an irradiance of 5 mW/cm2 (0.005 W/cm2), an energy density of 4.5 J/cm2, and an exposure duration of 900 s per session. Treatments were administered three times weekly for four weeks (12 sessions). Primary outcome measures included fasting blood glucose (Glucose AC) and glycated hemoglobin (HbA1c). Secondary outcomes included mean blood glucose, fasting insulin, C-peptide, homeostasis model assessment of insulin resistance (HOMA-IR), lipid profile, and C-reactive protein (CRP). Exploratory paired statistical analyses were performed following assessment of data normality using the Shapiro-Wilk test.

Results

Following the four-week intervention, fasting blood glucose and mean blood glucose were significantly reduced (p = 0.026 and p = 0.044, respectively), whereas HbA1c demonstrated a borderline reduction (p = 0.051). Changes in fasting insulin, C-peptide, HOMA-IR, lipid profile, and CRP were variable and did not reach statistical significance. No intervention-related adverse events were observed, and all participants completed the study protocol.

Conclusions

Multi-wavelength LED irradiation applied to the predefined S3 region of the skull was feasible, safe, and well tolerated in individuals with T2DM. The observed preliminary glycemic outcomes support the feasibility of further investigation in larger randomized controlled trials. However, because of the small sample size, absence of a control group, and exploratory study design, the present findings should be interpreted cautiously and should not be considered evidence of clinical efficacy or causal effects.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
940 nm
Energy density (fluence)
4.5 J/cm2
Power density (irradiance)
5 mW/cm2

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Light-emitting diode, Wavelength, Pilot study, Photobiomodulation, Statistical significance, Oxidative stress, Primary outcome, Control group. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies